The drugmaker presented Phase I data for the CD38xBCMAxCD3-directed trispecific at the International Myeloma Society meeting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results